Actual Incidence and Clinical Behaviour of Follicular Thyroid Carcinoma: An Institutional Experience

Table 2

HCC versus non-HCC patients: clinical, pathological, and follow-up characteristics.

	HCC	Non-HCC	𝑃 value
Patients	63	67
Age (±SD^a) (range) years	55.0±14.4 (18–85)	47.5±13.8 (21–88)	<0.01
Male/female	18/45	21/46	NS*
Tumour size (±SD^a) (range) mm	32.4±18.9 (6–100)	25.6±13.5 (5–65)	<0.05
Distant metastasis at diagnosis	1	3	NS*
pT stage
T1/T2/T3	14/30/19	22/33/12	NS*
pN stage
NX/N0/N1	62/0/1	67/0/0	NS*
pM stage
M0/M1	62/1	64/3	NS*
MI/WI	25/38	41/26	<0.05
Multifocal disease	3	1	NS*
Microcarcinoma	4	3	NS*
Concomitant PTC	8	13	NS*
Follow-up yes/no	58/5	59/8	NS*
Follow-up (±SD^a) (range) months	101.9±44.6 (17–179)	104.8±34.8 (29–174)	NS*
RAI/no RAI	55/3	50/9	NS*
Distant metastasis at follow-up	3	0	NS*

SD^a: standard deviation; NS*: not significant.